Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 21 May 2024

A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation

in Multiple Sclerosis and Neuroimmunology

Alexis F. League
Barkha J. Yadav-Samudrala
Ramya Kolagani
Calista A. Cline
Ian R. Jacobs
Jonathan Manke
Micah J. Niphakis
Benjamin F. Cravatt
Aron H. Lichtman
Bogna M. Ignatowska-Jankowska

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374301

5,913 views
3 citations

Original Research

Published on 14 May 2024

Serum NfL and EGFR/NfL ratio mRNAs as biomarkers for phenotype and disease severity of myelin oligodendrocyte glycoprotein IgG-associated disease

in Multiple Sclerosis and Neuroimmunology

Xin Wang
Yi Qu
Jiayu Fan
Huiqiang Ren

Frontiers in Immunology

doi 10.3389/fimmu.2024.1388734

2,762 views
6 citations

Original Research

Published on 03 May 2024

Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target

in Multiple Sclerosis and Neuroimmunology

Etianne Martini Sasso
Katsuhiko Muraki
Natalie Eaton-Fitch
Peter Smith
Andrew Jeremijenko
Paul Griffin
Sonya Marshall-Gradisnik

Frontiers in Immunology

doi 10.3389/fimmu.2024.1264702

13,515 views
7 citations

Brief Research Report

Published on 03 May 2024

Dimethyl fumarate modulates the regulatory T cell response in the mesenteric lymph nodes of mice with experimental autoimmune encephalomyelitis

in Multiple Sclerosis and Neuroimmunology

Amanda D. R. Lima
Breno B. Ferrari
Fernando Pradella
Rodrigo M. Carvalho
Sandra L. S. Rivero
Raphael P. S. Quintiliano
Matheus A. Souza
Natália S. Brunetti
Ana M. Marques
Irene P. Santos

Frontiers in Immunology

doi 10.3389/fimmu.2024.1391949

3,706 views
9 citations

Original Research

Published on 30 Apr 2024

Gas6/TAM system as potential biomarker for multiple sclerosis prognosis

in Multiple Sclerosis and Neuroimmunology

Davide D’Onghia
Donato Colangelo
Mattia Bellan
Stelvio Tonello
Chiara Puricelli
Eleonora Virgilio
Daria Apostolo
Rosalba Minisini
Luciana L. Ferreira
Leonardo Sozzi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1362960

4,528 views
7 citations

Original Research

Published on 30 Apr 2024

H-intensity scale score to estimate CSF GluN1 antibody titers with one-time immunostaining using a commercial assay

in Multiple Sclerosis and Neuroimmunology

Masaki Iizuka
Naomi Nagata
Naomi Kanazawa
Tomomi Iwami
Makoto Nagashima
Masaaki Nakamura
Juntaro Kaneko
Eiji Kitamura
Kazutoshi Nishiyama
Noritaka Mamorita

Frontiers in Immunology

doi 10.3389/fimmu.2024.1350837

3,016 views
2 citations

Original Research

Published on 30 Apr 2024

Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Cathérine Dekeyser
Pieter De Kesel
Melissa Cambron
Ludo Vanopdenbosch
Liesbeth Van Hijfte
Martine Vercammen
Guy Laureys

Frontiers in Immunology

doi 10.3389/fimmu.2024.1385231

5,310 views
13 citations

Original Research

Published on 29 Apr 2024

Interactions between circulating inflammatory factors and autism spectrum disorder: a bidirectional Mendelian randomization study in European population

in Multiple Sclerosis and Neuroimmunology

Junzi Long
Hui Dang
Wenlong Su
Md. Moneruzzaman
Hao Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1370276

10,164 views
9 citations

Original Research

Published on 25 Apr 2024

Exploring the common mechanism of vascular dementia and inflammatory bowel disease: a bioinformatics-based study

in Multiple Sclerosis and Neuroimmunology

Yujiao Wang
Daojun Xie
Shijia Ma
Nan Shao
Xiaoyan Zhang
Xie Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1347415

7,949 views
10 citations

Systematic Review

Published on 16 Apr 2024

Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Jianguo Yang
Yuying Sun
Xinpeng Zhou
Di Zhang
Ziqi Xu
Jiaojiao Cao
Bing Fan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1343971

6,975 views
4 citations

Case Report

Published on 11 Apr 2024

Case report: Atypical case of autoimmune glial fibrillary acidic protein astrocytopathy following COVID-19 vaccination refractory to immunosuppressive treatments

in Multiple Sclerosis and Neuroimmunology

Yuto Morishima
Takanori Hata
Sho Nakajima
Kazumasa Shindo
Mai Tsuchiya
Tsubasa Watanabe
Ippei Tahara
Tetsuo Kondo
Akio Kimura
Takayoshi Shimohata

Frontiers in Immunology

doi 10.3389/fimmu.2024.1361685

4,547 views
5 citations

Original Research

Published on 11 Apr 2024

Molecular dissection of an immunodominant epitope in Kv1.2-exclusive autoimmunity

in Multiple Sclerosis and Neuroimmunology

Ivan Talucci
Friederike A. Arlt
Kai O. Kreissner
Mahoor Nasouti
Anna-Lena Wiessler
Ramona Miske
Swantje Mindorf
Inga Dettmann
Mehrnaz Moniri
Markus Bayer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1329013

4,561 views
4 citations

Original Research

Published on 09 Apr 2024

Impact of inflammatory preconditioning on murine microglial proteome response induced by focal ischemic brain injury

in Multiple Sclerosis and Neuroimmunology

Dario Lucas Helbing
Fabienne Haas
Emilio Cirri
Norman Rahnis
Therese Thuy Dung Dau
Erika Kelmer Sacramento
Nova Oraha
Leopold Böhm
Trim Lajqi
Pascal Fehringer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1227355

4,430 views
3 citations

Correction

Published on 08 Apr 2024

Corrigendum: Characterization of pannexin1, connexin32, and connexin43 in spotted sea bass (Lateolabrax maculatus): they are important neuro-related immune response genes involved in inflammation-induced ATP release

in Multiple Sclerosis and Neuroimmunology

Zhaosheng Sun
Chong Xu
Yuxi Chen
Danjie Liu
Ping Wu
Qian Gao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1377603

1,033 views

Review

Published on 05 Apr 2024

Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review

in Multiple Sclerosis and Neuroimmunology

Óscar Fernández
Per Soelberg Sörensen
Giancarlo Comi
Patrick Vermersch
Hans-Peter Hartung
Letizia Leocani
Thomas Berger
Bart Van Wijmeersch
Celia Oreja-Guevara

Frontiers in Immunology

doi 10.3389/fimmu.2024.1379538

25,283 views
23 citations

Mini Review

Published on 05 Apr 2024

Microglial- neuronal crosstalk in chronic viral infection through mTOR, SPP1/OPN and inflammasome pathway signaling

in Multiple Sclerosis and Neuroimmunology

Catalina Argandona Lopez
Amanda M. Brown

Frontiers in Immunology

doi 10.3389/fimmu.2024.1368465

8,552 views
13 citations

Mini Review

Published on 04 Apr 2024

Aging brain: exploring the interplay between bone marrow aging, immunosenescence, and neuroinflammation

in Multiple Sclerosis and Neuroimmunology

Ludmila Müller
Svetlana Di Benedetto

Frontiers in Immunology

doi 10.3389/fimmu.2024.1393324

7,346 views
16 citations

Original Research

Published on 27 Mar 2024

Developing a novel immune infiltration-associated mitophagy prediction model for amyotrophic lateral sclerosis using bioinformatics strategies

in Multiple Sclerosis and Neuroimmunology

Rongrong Du
Peng Chen
Mao Li
Yahui Zhu
Zhengqing He
Xusheng Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1360527

4,945 views
6 citations

Review

Published on 27 Mar 2024

The intricate dance of non-coding RNAs in myasthenia gravis pathogenesis and treatment

in Multiple Sclerosis and Neuroimmunology

Benqiao Wang
Ying Zhu
Dan Liu
Chunxiang Hu
Ruixia Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1342213

3,957 views
4 citations

Mini Review

Published on 26 Mar 2024

Fructose overconsumption-induced reprogramming of microglia metabolism and function

in Multiple Sclerosis and Neuroimmunology

Kenneth K. Y. Ting

Frontiers in Immunology

doi 10.3389/fimmu.2024.1375453

7,658 views
13 citations

Review

Published on 26 Mar 2024

Biology of neurofibrosis with focus on multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Brian M. Lozinski
Samira Ghorbani
V. Wee Yong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1370107

5,028 views
2 citations

Original Research

Published on 26 Mar 2024

Evaluation of cyanotoxin L-BMAA effect on α-synuclein and TDP43 proteinopathy

in Multiple Sclerosis and Neuroimmunology

Paola Sini
Grazia Galleri
Cristina Ciampelli
Manuela Galioto
Bachisio Mario Padedda
Antonella Lugliè
Ciro Iaccarino
Claudia Crosio

Frontiers in Immunology

doi 10.3389/fimmu.2024.1360068

3,853 views
3 citations

Original Research

Published on 25 Mar 2024

Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease

in Multiple Sclerosis and Neuroimmunology

Jerzy K. Kulski
Shingo Suzuki
Takashi Shiina
Abigail L. Pfaff
Sulev Kõks

Frontiers in Immunology

doi 10.3389/fimmu.2024.1349030

6,450 views
13 citations

Original Research

Published on 21 Mar 2024

Reduced serum IgG galactosylation is associated with increased inflammation during relapses of neuromyelitis optica spectrum disorders

in Multiple Sclerosis and Neuroimmunology

Shiyu Gao
Xin Jiao
Ruoyi Guo
Xiujuan Song
Bin Li
Li Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1357475

3,644 views
3 citations

1,513 articles

articles

A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation

Serum NfL and EGFR/NfL ratio mRNAs as biomarkers for phenotype and disease severity of myelin oligodendrocyte glycoprotein IgG-associated disease

Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target

Dimethyl fumarate modulates the regulatory T cell response in the mesenteric lymph nodes of mice with experimental autoimmune encephalomyelitis

Gas6/TAM system as potential biomarker for multiple sclerosis prognosis

H-intensity scale score to estimate CSF GluN1 antibody titers with one-time immunostaining using a commercial assay

Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis

Interactions between circulating inflammatory factors and autism spectrum disorder: a bidirectional Mendelian randomization study in European population

Exploring the common mechanism of vascular dementia and inflammatory bowel disease: a bioinformatics-based study

Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis

Case report: Atypical case of autoimmune glial fibrillary acidic protein astrocytopathy following COVID-19 vaccination refractory to immunosuppressive treatments

Molecular dissection of an immunodominant epitope in Kv1.2-exclusive autoimmunity

Impact of inflammatory preconditioning on murine microglial proteome response induced by focal ischemic brain injury

Corrigendum: Characterization of pannexin1, connexin32, and connexin43 in spotted sea bass (Lateolabrax maculatus): they are important neuro-related immune response genes involved in inflammation-induced ATP release

Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review

Microglial- neuronal crosstalk in chronic viral infection through mTOR, SPP1/OPN and inflammasome pathway signaling

Aging brain: exploring the interplay between bone marrow aging, immunosenescence, and neuroinflammation

Developing a novel immune infiltration-associated mitophagy prediction model for amyotrophic lateral sclerosis using bioinformatics strategies

The intricate dance of non-coding RNAs in myasthenia gravis pathogenesis and treatment

Fructose overconsumption-induced reprogramming of microglia metabolism and function

Biology of neurofibrosis with focus on multiple sclerosis

Evaluation of cyanotoxin L-BMAA effect on α-synuclein and TDP43 proteinopathy

Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease

Reduced serum IgG galactosylation is associated with increased inflammation during relapses of neuromyelitis optica spectrum disorders